Edinburgh Research Explorer

Pathogenic Mutations in Retinitis Pigmentosa 2 Predominantly Result in Loss of RP2 Protein Stability in Human and Zebrafish

Research output: Contribution to journalArticlepeer-review

  • Fei Liu
  • Yayun Qin
  • Shanshan Yu
  • Dinesh C Soares
  • Lifang Yang
  • Jun Weng
  • Chang Li
  • Meng Gao
  • Zhaojing Lu
  • Xuebin Hu
  • Xiliang Liu
  • Tao Jiang
  • Jing Y Liu
  • Xinhua Shu
  • Zhaohui Tang
  • Mugen Liu

Related Edinburgh Organisations

Original languageEnglish
JournalJournal of Biological Chemistry
Early online date16 Feb 2017
DOIs
Publication statusPublished - 14 Apr 2017

Abstract

Mutations in retinitis pigmentosa 2 (RP2) account for 10-20% of X-linked retinitis pigmentosa (RP) cases. The encoded RP2 protein is implicated in ciliary trafficking of myristoylated and prenylated proteins in photoreceptor cells. To date, over 70 mutations in RP2 have been identified. How these mutations disrupt the function of RP2 is not fully understood. Here, we report a novel in-frame 12-bp deletion (c.357_368del, p.Pro120_Gly123del) in zebrafish rp2 The mutant zebrafish shows reduced rod phototransduction proteins and progressive retinal degeneration. Interestingly, the protein level of mutant Rp2 is almost undetectable, while its mRNA level is near normal, indicating a possible post-translational effect of the mutation. Consistent with this hypothesis, the equivalent 12-bp deletion in human RP2 markedly impairs RP2 protein stability and reduces its protein level. Furthermore, we found that a majority of the RP2 pathogenic mutations (including missense, single-residue deletion and C-terminal truncation mutations) severely destabilize the RP2 protein. The destabilized RP2 mutant proteins are degraded via the proteasome pathway, resulting in dramatically decreased protein levels. The remaining non-destabilizing mutations T87I, R118H/G/L/C, E138G and R211H/L are suggested to impair the interaction between RP2 and its protein partners (such as ARL3) or with as yet unknown partners. By utilizing a combination of in silico, in vitro and in vivo approaches, our work comprehensively indicates that loss of RP2 protein structural stability is the predominating pathogenic consequence for most RP2 mutations. Our study also reveals a role of the C-terminal domain of RP2 in maintaining the overall protein stability.

    Research areas

  • Journal Article

ID: 34856343